MIM
NVO

MTM Investment Management’s Novo Nordisk NVO Stock Holding History

MTM Investment Management’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$14.4K Hold
300
– – ﹤0.01% 491
2026
Q1 		$11K Hold
300
– – ﹤0.01% 509
2025
Q4 		$15.3K Hold
300
– – ﹤0.01% 476
2025
Q3 		$16.6K Hold
300
– – 0.01% 480
2025
Q2 		$20.7K Buy
+300
New +$20.4K 0.01% 441

Other funds holding NVO

Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $4.64B AUM 35.47% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

MTM Investment Management's NVO Position: Q2 2026 in Review

MTM Investment Management held its Novo Nordisk (NVO) position steady in Q2 2026 at 300 shares worth $14.4K. The position accounts for ﹤0.01% of the portfolio, ranked #491.

MTM Investment Management first reported a position in NVO in Q2 2025 and has held it in 5 quarters since. The position peaked at $20.7K in Q2 2025. 1,350 funds tracked by Wall St. Rank hold NVO as of Q2 2026.

  • MTM Investment Management held 300 shares of Novo Nordisk worth $14.4K as of Q2 2026.
  • MTM Investment Management left its Novo Nordisk share count unchanged in Q2 2026.
  • Novo Nordisk made up ﹤0.01% of MTM Investment Management's portfolio in Q2 2026, its #491 holding.
  • MTM Investment Management first reported a position in Novo Nordisk in Q2 2025 and has held it in 5 quarters since.
  • MTM Investment Management's Novo Nordisk position peaked at $20.7K in Q2 2025.
  • 1,350 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2026.

Based on MTM Investment Management's 13F filing for Q2 2026, filed 3 Aug 2026.